Related Experiment Video
Updated: Aug 5, 2026
09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Impaired Myogenic Differentiation Is a Shared Feature Across Genetic Myopathies
Tyler G B Soule1, Mikhaela B Slavin2, Carly S Pontifex1
1Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 4N1, Canada.
International Journal of Molecular Sciences
|July 28, 2026
Summary
Defective muscle differentiation is a common issue in genetic myopathies, impacting adult-onset conditions like FSHD and OPMD. Targeting muscle differentiation offers a potential therapeutic strategy for diverse myopathies.
Area of Science:
- Muscle biology
- Genetics
- Pathology
Background:
- Defective muscle differentiation is a hallmark of genetic myopathies.
- This process is well-studied in Duchenne muscular dystrophy and Emery-Dreifuss muscular dystrophy.
- It also affects adult-onset myopathies like FSHD, OPMD, and DM.
Purpose of the Study:
- To broaden the discussion on myopathies linked to differentiation defects.
- To examine implications in less characterized adult-onset muscle conditions.
- To highlight muscle differentiation as a potential therapeutic target.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of genetic myopathies with differentiation defects.
- Focus on adult-onset conditions and specific gene variants (FHL1, GNE, DES, CAPN3, HNRNP).
Main Results:
- Muscle differentiation defects are implicated in a wide range of genetic myopathies.
- These defects contribute to pathogenesis across diverse etiologies and molecular mechanisms.
- Satellite cell activation, differentiation, and fusion are crucial for muscle repair.
Conclusions:
- Muscle differentiation is central to the pathogenesis of various myopathies.
- Understanding these defects is key to developing effective treatments.
- Targeting muscle differentiation presents a promising therapeutic avenue.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:13Formation of Muscle Fibers from Myoblasts
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...